miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-107 | ||||
miRNA Stemloop AC | MI0000114 | ||||
miRNA Stemloop ID | hsa-mir-107 | ||||
Sequence | agcagcauuguacagggcuauca | ||||
TTD Target(s) Regulated by This miRNA | Cyclin-dependent kinase 6 (CDK6) | Successful Target | Target Info | [1] | |
Protein kinase C epsilon (PRKCE) | Successful Target | Target Info | [2] | ||
Interleukin-6 (IL6) | Successful Target | Target Info | [3] | ||
Janus kinase 1 (JAK-1) | Successful Target | Target Info | [3] | ||
Muscarinic acetylcholine receptor M1 (CHRM1) | Successful Target | Target Info | [4] | ||
Opioid receptor mu (MOP) | Successful Target | Target Info | [5] | ||
Vascular endothelial growth factor A (VEGFA) | Successful Target | Target Info | [6] | ||
Beta-secretase 1 (BACE1) | Clinical trial Target | Target Info | [7] | ||
Hypoxia-inducible factor 1 alpha (HIF-1A) | Clinical trial Target | Target Info | [8] | ||
Notch-2 receptor (NOTCH2) | Clinical trial Target | Target Info | [9] | ||
Kruppel like factor 4 (KLF4) | Clinical trial Target | Target Info | [10] | ||
Cyclin-dependent kinase 8 (CDK8) | Clinical trial Target | Target Info | [11] | ||
Large tumor suppressor homolog 2 (LATS2) | Literature-reported Target | Target Info | [12] | ||
Phosphatase and tensin homolog (PTEN) | Literature-reported Target | Target Info | [10] | ||
G1/S-specific cyclin-E1 (CCNE1) | Literature-reported Target | Target Info | [13] | ||
Maspin (SERPINB5) | Literature-reported Target | Target Info | [14] | ||
DNA repair protein RAD51 homolog 1 (RAD51) | Clinical trial Target | Target Info | [15] | ||
Forkhead box protein O1A (FOXO1) | Literature-reported Target | Target Info | [16] | ||
Caveolin 1 (CAV1) | Literature-reported Target | Target Info | [17] | ||
F-box and WD-40 domain protein 7 (Fbxw7) | Literature-reported Target | Target Info | [18] | ||
Gamma-synuclein (SNCG) | Literature-reported Target | Target Info | [19] | ||
Granulin (GRN) | Literature-reported Target | Target Info | [20] | ||
High mobility group protein HMGI-C (HMGA2) | Literature-reported Target | Target Info | [21] | ||
Protein(s) Regulated by This miRNA | Aryl hydrocarbon receptor nuclear translocator | Regulated Protein | [8] | ||
Axin-2 | Regulated Protein | [23] | |||
Cell division control protein 42 homolog | Regulated Protein | [24] | |||
Cell division cycle-associated protein 4 | Regulated Protein | [25] | |||
Chromogranin-A | Regulated Protein | [26] | |||
Circadian locomoter output cycles protein kaput | Regulated Protein | [27] | |||
Crk-like protein | Regulated Protein | [25] | |||
Cytochrome P450 2C8 | Regulated Protein | [28] | |||
Cytoplasmic polyadenylation element-binding protein 1 | Regulated Protein | [29] | |||
Death-associated protein kinase 1 | Regulated Protein | [10] | |||
E3 ubiquitin-protein ligase SIAH1 | Regulated Protein | [31] | |||
Endophilin-A1 | Regulated Protein | [32] | |||
Neurofibromin | Regulated Protein | [33] | |||
Nuclear factor 1 A-type | Regulated Protein | [34] | |||
Protein argonaute-1 | Regulated Protein | [35] | |||
Protein lin-28 homolog A | Regulated Protein | [36] | |||
Ras-related protein Rab-1B | Regulated Protein | [25] | |||
Sal-like protein 4 | Regulated Protein | [37] | |||
Zinc finger protein PLAG1 | Regulated Protein | [38] | |||
References | |||||
REF 1 | Physiological identification of human transcripts translationally regulated by a specific microRNA. Hum Mol Genet. 2005 Dec 15;14(24):3813-21. | ||||
REF 2 | microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase C. Oncogene. 2012 Sep 6;31(36):4045-53. | ||||
REF 3 | Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis. J Virol. 2014 Apr;88(7):3733-43. | ||||
REF 4 | Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA. Transl Psychiatry. 2013 Feb 19;3:e230. | ||||
REF 5 | Morphine regulates expression of -opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the -opioid receptor (OPRM1) gene via miR-103/miR-107. Mol Pharmacol. 2014 Feb;85(2):368-80. | ||||
REF 6 | The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One. 2008 Mar 5;3(3):e1719. | ||||
REF 7 | The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci. 2008 Jan 30;28(5):1213-23. | ||||
REF 8 | P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9. | ||||
REF 9 | P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. Neurosci Lett. 2013 Feb 8;534:327-32. | ||||
REF 10 | miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 2012 Jul 15;72(14):3631-41. | ||||
REF 11 | MicroRNA-107 promotes proliferation of gastric cancer cells by targeting cyclin dependent kinase 8. Diagn Pathol. 2014 Aug 28;9:164. | ||||
REF 12 | miR-107 and miR-25 simultaneously target LATS2 and regulate proliferation and invasion of gastric adenocarcinoma (GAC) cells. Biochem Biophys Res Commun. 2015 May 8;460(3):806-12. | ||||
REF 13 | miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 2008 Sep;36(16):5391-404. | ||||
REF 14 | miRNA-7/21/107 contribute to HBx-induced hepatocellular carcinoma progression through suppression of maspin. Oncotarget. 2015 Sep 22;6(28):25962-74. | ||||
REF 15 | Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity. Mol Cancer Res. 2013 Dec;11(12):1564-73. | ||||
REF 16 | Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1. FEBS Lett. 2014 Feb 14;588(4):538-44. | ||||
REF 17 | miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1. Tumour Biol. 2015 Apr;36(4):2277-85. | ||||
REF 18 | Anti-Argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes. RNA. 2010 Feb;16(2):394-404. | ||||
REF 19 | Cell-specific post-transcriptional regulation of -synuclein gene by micro-RNAs. PLoS One. 2013 Sep 11;8(9):e73786. | ||||
REF 20 | miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol. 2010 Jul;177(1):334-45. | ||||
REF 21 | Biochem Biophys Res Commun. 2016 Nov 18;480(3):455-460. | ||||
REF 22 | P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9. | ||||
REF 23 | MicroRNAs modulate the Wnt signaling pathway through targeting its inhibitors.Biochem Biophys Res Commun. 2011 May 6;408(2):259-64. | ||||
REF 24 | miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42. Oncol Rep. 2017 May;37(5):3116-3127. | ||||
REF 25 | MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One. 2009 Aug 18;4(8):e6677. | ||||
REF 26 | Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.J Am Soc Nephrol. 2015 Aug;26(8):1816-25. | ||||
REF 27 | Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system.Mol Nutr Food Res. 2015 Mar;59(3):552-65. | ||||
REF 28 | Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver.Mol Pharmacol. 2012 Sep;82(3):529-40. | ||||
REF 29 | MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.Oncotarget. 2016 Jan 5;7(1):266-78. | ||||
REF 30 | miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 2012 Jul 15;72(14):3631-41. | ||||
REF 31 | MiR-107 down-regulates SIAH1 expression in human breast cancer cells and silencing of miR-107 inhibits tumor growth in a nude mouse model of triple-negative breast cancer.Mol Carcinog. 2016 May;55(5):768-77. | ||||
REF 32 | MicroRNA-107 prevents amyloid-beta induced blood-brain barrier disruption and endothelial cell dysfunction by targeting Endophilin-1.Exp Cell Res. 2016 May 1;343(2):248-257. | ||||
REF 33 | miR-107 regulates tumor progression by targeting NF1 in gastric cancer.Sci Rep. 2016 Nov 9;6:36531. | ||||
REF 34 | MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene. 2007 Jun 14;26(28):4148-57. | ||||
REF 35 | Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis.J Clin Invest. 2013 Mar;123(3):1057-67. | ||||
REF 36 | Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107.PLoS One. 2015 Dec 4;10(12):e0143716. | ||||
REF 37 | Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4.Int J Biochem Cell Biol. 2013 Sep;45(9):1962-73. | ||||
REF 38 | miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.Blood. 2009 Oct 8;114(15):3255-64. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.